1. Houdebine LM. Production of pharmaceutical
proteins by transgenic animals. Comparative
Immunology Microbiology and Infectious
Diseases. 2009;32:107-21
2. Snaith MR, Tornell J. The use of transgenic
systems in pharmaceutical research. Briefings
in Functional Genomics and Proteomics.2002;
1 (2): 119-30.
3. RDS: Understanding Animal Research in
medicine and coalition for medical progress.
Medical Advances And Animal Research The
contribution of Animal Sciences to the Medical
Revolution: Some Case Histories. [Serial on
the Internet]. 2007. [Cited 2012 Nov 21];
Available from http://www.protest.
org.uk/MAAR.pdf
4. Niemann H, Kues W, Carnwath JW.
Transgenic farm animals: present and future.
Rev.sci.tech. Off. Int. Epiz. 2005;24(1):285-98
5. McLaughlin PMJ. Kroesen BJ, Harmsen MC.
Lou FMH. Cancer immunotherapy: insights
from transgenic animal models. Critical
reviews in Oncology/Hematology.2001; 40:53-
76
6. Kandhare AD, Raygude KS, Ghosh P, Gosavi
TP, Bodhankar SL. Patentability of Animal
Models: India and the Globe. International
Journal of Pharmaceutical and Biological
Archives. 2011; 2(4):1024-32.
7. Applied Research Ethics National Association.
Institutional Animal Care and Use Committee
Guidebook. [Homepage on the Internet]. 2002.
[Cited 2012 Oct05]. Available from
http://grants.nih.gov/grants/olaw/guidebook.pd
f
8. United States Food and Drug Administration.
Points To Consider In The Manufacture And
Testing Of Therapeutic Products For Human
Use Derived From Transgenic Animals.
[Homepage on the Internet]. 1995. [cited 2012
114
Bagle TR et al., Int J Med Res Health Sci. 2012;2(1):107-116
Nov 05]; Available from
http://www.fda.gov/downloads/BiologicsBlood
Vaccines/GuidanceComplianceRegulatoryInfor
mation/OtherRecommendationsforManufacture
rs/UCM153306.pdf
9. Volume with supplement: Montgomery A.
Transgenic animals walking bioreactors.
BioProcess International. 2004. 40-51.
10. Jube S, Borthakur D. Recent advances in food
biotechnology research. In: Hui YH, Nip W-K,
Nollet LML, Paliyath G, Sahlstrom S, Simpson
BK editors. Food Biochemistry and Food
Processing. Oxford: Blackwell Publishing,
2006; p 35-70.
11. Rosential P. Gharavi A, Agati VD. Klotman P.
Transgenic and Infectious Animal Models of
HIV-Associated Nephropathy. J Am Soc
Nephrol.2009; 20:2296-304.
12. Joshi PC. Guidot DM. HIV-1 transgene
expression in rats induces differential
expression of tumour necrosis factor alpha and
zinc transporters in the liver and the lung.
AIDS Research and Therapy. 2011;8(36):1-11.
13. Spires TL. Bradley TH. Transgenic Models of
Alzheimer’s disease: Learning from Animals.
The Journal of the American Society for
Experimental Neurotherapeutics.2005; 2 (3):
423-37.
14. Gotz J, Streffer JR, David D, Schild A,
Hoerndli F, Pennanen L etal. Transgenic
animal models of Alzheimer’s disease and
related disorders: histopathology, behaviour
and therapy. Molecular Psychiatry. 2004;
9:664-83.
15. Schenk D. Amyloid-β immunotherapy for
Alzheimer’s disease: the end of the beginning.
Nature Reviews/Neuroscience. 2002; 3:824-28.
16. Bader M, Bohnemeier H, Zollmann FS,
LockleyJones OE, Ganten D. Transgenic
animals in cardiovascular disease research.
Experimental Physiology.2000; 85(6):713-31.
17. Hasenfuss G. Animal models of human
cardiovascular disease, heart failure and
hypertrophy. Cardiovascular Research. 1998;
39:60-76.
18. Srinivasan K. Ramarao P. Animal models in
type 2 diabetes research: an overview. Indian J
Med Res. 2007; 125: 451-72.
19. Etuk EU. Animal models for studying diabetes
mellitus. Agri. Bio. J. N. Am. 2010; 1(2): 130-
34.
20. Henson MS. Timothy DO. Feline Models of
type 2 Diabetes Mellitus. ILAR Journal. 2006;
47(3):234-42.
21. Kumar S. Singh R. Vasudeva N. Sharma S.
acute and chronic animal models for the
evaluation of antidiabetic agents.
Cardiovascular Diabetology. 2012; 11(9):1-13.
22. Eddouks M. Chattopadhyay, Zeggwagh NA.
Animal models as tools to investigate
antidiabetic and anti-inflammatory plants.
Evidence based Complementary and
Alternative Medicine. 2012. 1-14.
23. Carmeliet P. Moons L. Collen D. Mouse
models of angiogenesis, arterial stenosis,
atherosclerosis and hemostasis. Cardiovascular
Research. 1998;39:8-33.
24. Boverhof DR. Chamberlain MP. Elcombe CR.
Gonzalez FJ. Heflich RH. Lya GH. Transgenic
animal models in Toxicology: Historical
Perspectives and Future Outlook.
2011;121(2):207-33.
25. World Health Organization. Transgenic
Animal Mutagenicity Assays. [Homepage on
the Internet]. 2006. [cited 2012 Nov 03];
Available from
http://www.inchem.org/documents/ ehc /
ehc/ehc233.pdf
26. Pavlaki M, Zucker S. Matrix Metalloproteinase
inhibitors (MMPIs): The beginning of Phase I
or the termination of phase III clinical trials.
Cancer and metastasis reviews. 2003; 22:177-
03
27. Ramaswamy S. McBride JL, Kordower H.
Animal Models of Huntington’s Disease. ILAR
Journal. 2007; 48(4):356-73.
28. Horton WA. Skeletal development: insights
from targeting the mouse genome. Lancet.
2003; 362:560-69.
115
Bagle TR et al., Int J Med Res Health Sci. 2012;2(1):107-116
29. Ormandy EH. Dale J, Griffin G. Genetic
engineering of animals. Ethical issues,
including welfare concerns. CVJ.2011; 52:544-
52
30. Prather RS. Shen M, Dai Y. Genetically
modified Pigs for medicine and Agriculture.
Biotechnology and Genetic Engineering
Reviews. 2008; 25:245-66.
31. Hunter CV, Tiley LS, Sang HM. Development
in transgenic technology: applications for
medicine. TRENDS in Molecular
Medicine.2005; 11 (6): 293-98.
32. Alison VE. Genetically Engineered Animals:
An overview. [Serial on the Internet]. 2008.
[Cited 2012 Nov 25]; Available from
http://animalscience.ucdavis.edu/animalbiotech
/Outreach/Genetically_engineered_animals_ov
erview.pdf
33. Lonberg N. Human antibodies from transgenic
animals. Nature Biotechnology.
2005;23(9):1117-1125
34. Niemann H, Kues WA. Application of
transgenesis in livestock for agriculture and
biomedicine. Animal Reproduction Science.
2003;79:291-317.
35. Fung J, Rao A, Starzl T. Clinical trials and
Projected future of Liver Xenotransplantation.
World Journal of Surgery.1997; 21:956-61.
36. Cooper DK. Clinical Xenotransplantation-how
close are we?. Lancet. 2003; 362:557-59.
37. Alison LE. What is the future of animal
biotechnology?. California Agriculture. 2006;
60( 3):132-139.
38. Einsiedel EF. Public perceptions of Transgenic
animals. Rev. Sci. tech. Off. Int. Epiz. 2005;
24(1):149-157.
39. Special Issue: Mertens C, Rulicke T. Welfare
Assessment and Phenotype Characterisation of
Transgenic Mice. Altex. 2007;24: 46-48
40. Indian Council of Medical Research. The Use
of Animals in Scientific Research. [Homepage
on the Internet]. 2008. [Cited 2012 Dec 03];
Available from http: //icmr. nic.
in/bioethics/Animals_biomedical%20research.
pdf
41. The Parliamentary Office of Science and
Technology. Biomedical Patents. [homepage
on the Internet]. 2012. [cited 2012 Dec 01];
Available from http://www.parliament.uk/
Templates/BriefingPapers/Pages/BPPdfDownl
oad.aspx?bp-id=POST-PN-401
42. Rigaud N. OECD International Futures Project
on “The Bioeconomy to 2030: Designing
Policy Agenda”. Biotechnology: Ethical and
social debates. [homepage on the Internet].
2008. [cited 2012 Dec 01]; Available from
http://www.biotechnologie.de/BIO/Redaktion/
PDF/de/laenderfokus/indien-oecd-vollberichtmitanhang,
property=pdf,bereich=bio,sprache=de,r
wb=true.pdf
43. Goldman IL, Kadulin SG, Razin SV.
Transgenic animals in medicine: Integrations
and expression of foreign genes, theoretical
and applied aspects. Med SciMonit. 2004;10
(11): RA274-285.
44. Huang YJ, Huang Y, Baldassarre H, Wang B,
Lazaris A, Leduc M. Recombinant Human
Butyrylcholinesterase from the milk of
transgenic animals to protect against
organophosphate poisoning. PNAS. 2007;
104(34):13603-13608.
45. Park F. Lentivirus vectors: are they the future
of animal transgenesis?. Physiol. Genomics.
2007; 31:159-173
Thank you for copying data from http://www.arastirmax.com
